Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 11 | 205,782 | $7.09M |
| Option exercise | 28 | 469,968 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
89 Form 4 filings on record, the earliest from Nov 21, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Amir Weiss - Officer | Open-market sale | Ordinary Shares | 10,679 | $36.00 | $384K | |
| Richard Daniell - Officer | Open-market sale | Ordinary Shares | 30,000 | $35.40 | $1.06M | |
| Mark Sabag - Officer | Open-market sale | Ordinary Shares | 144,180 | $34.99 | $5.05M | |
| Christine Fox - Officer | Open-market sale | Ordinary Shares | 21,258 | $35.31 | $751K | |
| Mark Sabag - Officer | Open-market sale | Ordinary Shares | 62,102 | $30.14 | $1.87M | |
| Mark Sabag - Officer | Option exercise | Restricted Share Units | 15,723 | $0.00 | - | |
| Mark Sabag - Officer | Option exercise | Ordinary Shares | 15,723 | - | - | |
| Eliyahu Sharon Kalif - Officer | Option exercise | Ordinary Shares | 19,916 | - | - | |
| Eliyahu Sharon Kalif - Officer | Option exercise | Restricted Share Units | 19,916 | $0.00 | - | |
| Amir Weiss - Officer | Option exercise | Ordinary Shares | 3,537 | - | - | |
| Amir Weiss - Officer | Option exercise | Restricted Share Units | 3,537 | $0.00 | - | |
| Richard D. Francis - Officer | Open-market sale | Ordinary Shares | 20,025 | $31.67 | $634K | |
| Richard D. Francis - Officer | Option exercise | Restricted Share Units | 42,452 | $0.00 | - | |
| Richard D. Francis - Officer | Option exercise | Ordinary Shares | 42,452 | - | - | |
| Christine Fox - Officer | Option exercise | Restricted Share Units | 17,819 | $0.00 | - | |
| Christine Fox - Officer | Option exercise | Ordinary Shares | 17,819 | - | - | |
| Christine Fox - Officer | Open-market sale | Ordinary Shares | 7,924 | $31.67 | $251K | |
| Eric A. Hughes - Officer | Option exercise | Restricted Share Units | 19,654 | $0.00 | - | |
| Eric A. Hughes - Officer | Option exercise | Ordinary Shares | 19,654 | - | - | |
| Eric A. Hughes - Officer | Open-market sale | Ordinary Shares | 9,533 | $31.67 | $302K | |
| Richard Daniell - Officer | Open-market sale | Ordinary Shares | 17,295 | $31.67 | $548K | |
| Richard Daniell - Officer | Option exercise | Restricted Share Units | 17,295 | $0.00 | - | |
| Richard Daniell - Officer | Option exercise | Ordinary Shares | 17,295 | - | - | |
| Placid Jover - Officer | Open-market sale | Ordinary Shares | 14,150 | $31.67 | $448K | |
| Placid Jover - Officer | Option exercise | Restricted Share Units | 14,150 | $0.00 | - | |
| Placid Jover - Officer | Option exercise | Ordinary Shares | 14,150 | - | - | |
| Brian Savage - Officer | Option exercise | Ordinary Shares | 3,580 | - | - | |
| Brian Savage - Officer | Open-market sale | Ordinary Shares | 1,127 | $31.67 | $36K | |
| Brian Savage - Officer | Option exercise | Restricted Share Units | 3,580 | $0.00 | - | |
| Matthew Shields - Officer | Open-market sale | Ordinary Shares | 17,295 | $31.67 | $548K | |
| Matthew Shields - Officer | Option exercise | Restricted Share Units | 17,295 | $0.00 | - | |
| Matthew Shields - Officer | Option exercise | Ordinary Shares | 17,295 | - | - | |
| Richard D. Francis - Officer | Open-market sale | Ordinary Shares | 23,393 | $32.46 | $759K | |
| Richard D. Francis - Officer | Option exercise | Restricted Share Units | 50,223 | $0.00 | - | |
| Richard D. Francis - Officer | Grant or award | Restricted Share Units | 136,736 | $0.00 | - | |
| Richard D. Francis - Officer | Option exercise | Ordinary Shares | 50,223 | - | - | |
| Richard Daniell - Officer | Open-market sale | Ordinary Shares | 33,512 | $32.46 | $1.09M | |
| Richard Daniell - Officer | Open-market sale | Ordinary Shares | 20,461 | $32.46 | $664K | |
| Richard Daniell - Officer | Open-market sale | Ordinary Shares | 37,372 | $32.95 | $1.23M | |
| Richard Daniell - Officer | Option exercise | Restricted Share Units | 33,512 | $0.00 | - | |
| Richard Daniell - Officer | Option exercise | Restricted Share Units | 20,461 | $0.00 | - | |
| Richard Daniell - Officer | Grant or award | Restricted Share Units | 33,424 | $0.00 | - | |
| Richard Daniell - Officer | Option exercise | Ordinary Shares | 33,512 | - | - | |
| Richard Daniell - Officer | Option exercise | Ordinary Shares | 20,461 | - | - | |
| Placid Jover - Officer | Grant or award | Restricted Share Units | 37,982 | $0.00 | - | |
| Matthew Shields - Officer | Grant or award | Restricted Share Units | 33,424 | $0.00 | - | |
| Mark Sabag - Officer | Option exercise | Ordinary Shares | 33,512 | - | - | |
| Mark Sabag - Officer | Option exercise | Ordinary Shares | 18,601 | - | - | |
| Mark Sabag - Officer | Option exercise | Restricted Share Units | 33,512 | $0.00 | - | |
| Mark Sabag - Officer | Option exercise | Restricted Share Units | 18,601 | $0.00 | - | |
| Mark Sabag - Officer | Grant or award | Restricted Share Units | 30,385 | $0.00 | - | |
| Evan Lippman - Officer | Grant or award | Restricted Share Units | 27,347 | $0.00 | - | |
| Eric A. Hughes - Officer | Open-market sale | Ordinary Shares | 11,277 | $32.46 | $366K | |
| Eric A. Hughes - Officer | Option exercise | Restricted Share Units | 23,251 | $0.00 | - | |
| Eric A. Hughes - Officer | Grant or award | Restricted Share Units | 50,643 | $0.00 | - | |
| Eric A. Hughes - Officer | Option exercise | Ordinary Shares | 23,251 | - | - | |
| Eliyahu Sharon Kalif - Officer | Option exercise | Ordinary Shares | 23,251 | - | - | |
| Eliyahu Sharon Kalif - Officer | Option exercise | Restricted Share Units | 33,512 | $0.00 | - | |
| Eliyahu Sharon Kalif - Officer | Option exercise | Restricted Share Units | 23,251 | $0.00 | - | |
| Eliyahu Sharon Kalif - Officer | Grant or award | Restricted Share Units | 53,175 | $0.00 | - | |
| Eliyahu Sharon Kalif - Officer | Option exercise | Ordinary Shares | 33,512 | - | - | |
| Christine Fox - Officer | Option exercise | Ordinary Shares | 20,461 | - | - | |
| Christine Fox - Officer | Open-market sale | Ordinary Shares | 9,098 | $32.46 | $295K | |
| Christine Fox - Officer | Option exercise | Restricted Share Units | 20,461 | $0.00 | - | |
| Christine Fox - Officer | Grant or award | Restricted Share Units | 50,643 | $0.00 | - | |
| Brian Savage - Officer | Open-market sale | Ordinary Shares | 1,489 | $32.46 | $48K | |
| Brian Savage - Officer | Option exercise | Ordinary Shares | 3,466 | - | - | |
| Brian Savage - Officer | Open-market sale | Ordinary Shares | 1,186 | $32.46 | $39K | |
| Brian Savage - Officer | Option exercise | Restricted Share Units | 4,744 | $0.00 | - | |
| Brian Savage - Officer | Option exercise | Restricted Share Units | 3,766 | $0.00 | - | |
| Brian Savage - Officer | Grant or award | Restricted Share Units | 11,280 | $0.00 | - | |
| Brian Savage - Officer | Option exercise | Ordinary Shares | 4,744 | - | - | |
| Amir Weiss - Officer | Option exercise | Ordinary Shares | 10,679 | - | - | |
| Amir Weiss - Officer | Option exercise | Ordinary Shares | 5,650 | - | - | |
| Amir Weiss - Officer | Option exercise | Restricted Share Units | 10,679 | $0.00 | - | |
| Amir Weiss - Officer | Option exercise | Restricted Share Units | 5,650 | $0.00 | - | |
| Amir Weiss - Officer | Grant or award | Restricted Share Units | 11,280 | $0.00 | - | |
| Amir Weiss - Officer | Option exercise | Ordinary Shares | 5,179 | - | - | |
| Amir Weiss - Officer | Option exercise | Restricted Share Units | 5,179 | $0.00 | - | |
| Richard Daniell - Officer | Open-market sale | Ordinary Shares | 62,250 | $32.36 | $2.01M | |
| Richard Daniell - Officer | Option exercise | Ordinary Shares | 141,478 | - | - | |
| Richard Daniell - Officer | Open-market sale | Ordinary Shares | 66,735 | $32.36 | $2.16M | |
| Richard Daniell - Officer | Option exercise | Restricted Share Units | 62,250 | $0.00 | - | |
| Richard Daniell - Officer | Option exercise | Restricted Share Units | 141,478 | $0.00 | - | |
| Richard Daniell - Officer | Option exercise | Ordinary Shares | 62,250 | - | - | |
| Mark Sabag - Officer | Option exercise | Restricted Share Units | 24,900 | $0.00 | - | |
| Mark Sabag - Officer | Option exercise | Restricted Share Units | 141,478 | $0.00 | - | |
| Mark Sabag - Officer | Option exercise | Ordinary Shares | 24,900 | - | - | |
| Mark Sabag - Officer | Option exercise | Ordinary Shares | 141,478 | - | - | |
| Brian Savage - Officer | Open-market sale | Ordinary Shares | 1,274 | $32.36 | $41K | |
| Brian Savage - Officer | Option exercise | Restricted Share Units | 3,461 | $0.00 | - | |
| Brian Savage - Officer | Option exercise | Ordinary Shares | 3,461 | - | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Lippman Evan | Officer, EVP BUSINESS DEVELOPMENT | 18,600 | $680K | View on EDGAR | |
| Jover Placid | Executive VP, Chief HR Officer | 12,827 | $447K | View on EDGAR | |
| Hughes Eric A | Executive VP Global R&D and Chief Med Officer | 25,578 | $892K | View on EDGAR |
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) had 19 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for TEVA runs to 89 Form 4 filings, the earliest from 2024-11-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TEVA were filed in the last 90 days. 1 purchase is on record for this company.
11 insider sales of TEVA were filed in the last 90 days, totaling $7.09M.
This page tracks TEVA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TEVA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.